Virpax Pharmaceuticals Inc (VRPX)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current VRPX market cap is 1.86M. The company's latest EPS is USD -3.1079 and P/E is -0.12.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -6.12M | -4.68M | -3.3M | -3.46M | -1.92M |
| Net Income | -6M | -4.56M | -3.22M | -3.45M | -2.01M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.18M | -4.2M | -12.03M | -21.85M | -15.69M |
| Net Income | -3.31M | -4.34M | -12.06M | -21.65M | -15.19M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 13.04M | 9.63M | 3.13M | 2.59M | 304k |
| Total Liabilities | 6.53M | 7.69M | 4.34M | 5.39M | 2.36M |
| Total Equity | 6.51M | 1.93M | -1.21M | -2.79M | -2.05M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 47k | 465k | 39.57M | 19.67M | 9.63M |
| Total Liabilities | 2.78M | 4.68M | 2.09M | 3.1M | 7.69M |
| Total Equity | -2.73M | -4.22M | 37.49M | 16.58M | 1.93M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -6.84M | -9.85M | -7.73M | -9.37M | -13.84M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | N/A | N/A | 453k | 2.1M | 4.72M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -1.13M | -1.39M | -14.54M | -17.85M | -9.85M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 1.13M | 1.4M | 54.35M | N/A | N/A |
| Market Cap | 1.86M |
| Price to Earnings Ratio | -0.12 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.2 |
| Price to Book Ratio | 0.96 |
| Dividend Yield | - |
| Shares Outstanding | 4.89M |
| Average Volume (1 week) | 3.41M |
| Average Volume (1 Month) | 1.79M |
| 52 Week Change | -87.59% |
| 52 Week High | 5.48 |
| 52 Week Low | 0.286 |
| Spread (Intraday) | 0.01 (2.56%) |
| Company Name | Virpax Pharmaceuticals Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.virpaxpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
